4-(2-吗啉-4-基乙氧基)-1-萘胺 | 317806-90-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 4-(2-吗啉-4-基乙氧基)-1-萘胺
• 中文别名: 4-(2-N-吗啉基乙氧基)萘-1-胺
• 英文名称: 4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-ylamine
• 英文别名: 4-(2-Morpholinoethoxy)naphthalen-1-amine；4-(2-morpholin-4-ylethoxy)naphthalen-1-amine
• CAS: 317806-90-9
• 化学式: C₁₆H₂₀N₂O₂
• 分子量: 272.347
• InChiKey: MROVYGBBVOSFPE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  47.7
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  4-(2-吗啉-4-基乙氧基)-1-萘胺 以 四氢呋喃 、 甲醇 、 乙酸乙酯 为溶剂， 生成 1-[4-(2-Morpholin-4-yl-ethoxy)-naphthalen-1-yl]-3-(2-phenyl-cyclopropyl)-urea
  参考文献：
  名称：

  1,4-disubstituted benzo-fused cycloalkyl urea compounds

  摘要：

  公开了以下式子（I）的化合物，其作为抗炎剂具有活性。同时公开了使用和制备这样的化合物的方法。其中n、X、A、L、J、p、Q、Y和z的描述如下。

  公开号：

  US20030100608A1
• 作为产物：
  描述：

  4-氨基-1-萘酚 在 盐酸 、 potassium carbonate 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 乙腈 为溶剂， 反应 23.0h， 生成 4-(2-吗啉-4-基乙氧基)-1-萘胺
  参考文献：
  名称：

  Pyrazole Urea-Based Inhibitors of p38 MAP Kinase:  From Lead Compound to Clinical Candidate

  摘要：

  We report on a series of N-pyrazole, N'-aryl ureas and their mode of binding to p38 mitogen activated protein kinase. Importantly, a key binding domain that is distinct from the adenosine 5'-triphoshate (ATP) binding site is exposed when the conserved activation loop, consisting in part of Asp168-Phe169-Gly170, adopts a conformation permitting lipophilic and hydrogen bonding interactions between this class of inhibitors and the protein. We describe the correlation of the structure-activity relationships and crystallographic structures of these inhibitors with p38. In addition, we incorporated another binding pharmacophore that forms a hydrogen bond at the ATP binding site. This modification affords significant improvements in binding, cellular, and in vivo potencies resulting in the selection of 45 (BIRB 796) as a clinical candidate for the treatment of inflammatory diseases.

  DOI：

  10.1021/jm020057r

文献信息

• 1,4-Benzofused urea compounds useful in treating cytokine mediated diseases
  申请人：Boehringer Ingelheim Pharmaceuticals, Inc.

  公开号：US20030232865A1

  公开（公告）日：2003-12-18

  Disclosed are 1,4-disubstituted benzo-fused urea compounds of formula (I): 1 wherein Ar, X, A, L, and Q of formula(I) are defined herein. The compounds inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.

  披露了公式(I)的1,4-二取代苯并尿素化合物：1其中，公式(I)中的Ar、X、A、L和Q在本文中定义。这些化合物抑制参与炎症过程的细胞因子的产生，因此可用于治疗涉及炎症的疾病和病理状况，如慢性炎症疾病。还披露了制备这些化合物的方法以及包含这些化合物的药物组合物。
• Methods of treating cytokine mediated diseases
  申请人：Boehringer Ingelheim Pharmaceuticals, Inc.

  公开号：US20030130309A1

  公开（公告）日：2003-07-10

  Disclosed are methods of treating certain cytokine mediated diseases or conditions using novel aromatic heterocyclic compounds of the formula(I) wherein Ar 1 ,Ar 2 ,L,Q and X are described herein. 1

  披露了使用公式(I)中描述的新芳香杂环化合物治疗特定细胞因子介导的疾病或症状的方法，其中Ar1，Ar2，L，Q和X如下所述。
• Aromatic heterocyclic compounds as antiinflammatory agents
  申请人：Boehringer Ingelheim Pharmaceuticals, Inc.

  公开号：US06525046B1

  公开（公告）日：2003-02-25

  Disclosed are novel aromatic heterocyclic compounds of the formula(I) wherein Ar1,Ar2,L,Q and X are described herein. The compounds are useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are processes of making such compounds.

  揭示了一种新颖的芳香杂环化合物，其化学式为(I)，其中Ar1、Ar2、L、Q和X如本文所述。这些化合物在制备用于治疗涉及炎症的疾病或病理状况，如慢性炎症性疾病的药物组合物中具有用途。还公开了制备这种化合物的方法。
• 1,4-Disubstituted benzo-fused compounds
  申请人：——

  公开号：US20030083333A1

  公开（公告）日：2003-05-01

  Disclosed are novel 1,4-disubstituted benzo-fused compounds wherein G, X, L, Q, n and Y are defined herein. The compounds are useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are processes of making such compounds. 1

  揭示了一种新型的1,4-二取代苯并化合物，其中G、X、L、Q、n和Y在此定义。这些化合物在制备用于治疗涉及炎症的疾病或病理状况的药物组合物中很有用，如慢性炎症性疾病。还公开了制备这些化合物的方法。
• Compounds useful as anti-inflammatory agents
  申请人：Boehringer Ingelheim Pharmaceuticals, Inc.

  公开号：US06492393B1

  公开（公告）日：2002-12-10

  Disclosed are novel aromatic compounds of the formula (I) wherein G, X, Ar, L and Q are defined herein. The compounds are useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are processes of making such compounds.

  揭示了一种新颖的芳香化合物，其化学式为（I），其中G、X、Ar、L和Q在此处有定义。这些化合物在制备用于治疗涉及炎症的疾病或病理状况的药物组合物中具有用途，如慢性炎症性疾病。还揭示了制备这些化合物的方法。